• Multiple Myeloma — An Interview with Dr Surbhi Sidana on Optimizing the Role of CAR T-Cell Therapy

  • Feb 19 2025
  • Durée: 47 min
  • Podcast

Multiple Myeloma — An Interview with Dr Surbhi Sidana on Optimizing the Role of CAR T-Cell Therapy

Écouter gratuitement

Voir les détails du balado

  • Résumé

  • Featuring an interview with Dr Surbhi Sidana, including the following topics:

    • Long-term outcomes for patients with relapsed/refractory multiple myeloma (MM) (0:00)
    • Clinical considerations in the selection of patients for chimeric antigen receptor (CAR) T-cell therapy (3:34)
    • Practical challenges for patients receiving CAR T-cell therapy (8:34)
    • Selection among available CAR T-cell therapies (12:18)
    • Prevention, management and supportive care involved in the management of toxicities associated with CAR T-cell therapy (16:34)
    • Secondary cancers associated with CAR T-cell therapy (21:25)
    • Bridging therapy considerations for patients receiving CAR T-cell treatment (25:15)
    • Utility of antibody-drug conjugates and bispecific antibodies for MM (27:49)
    • Case: A man in his early 40s experiences rapid progression on induction therapy for MM (31:59)
    • Case: A man in his early 50s with heavily pretreated MM receives multiple CAR T-cell therapies (41:47)

    CME information and select publications
    Voir plus Voir moins
Voir plus Voir moins

Ce que les auditeurs disent de Multiple Myeloma — An Interview with Dr Surbhi Sidana on Optimizing the Role of CAR T-Cell Therapy

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.

Évaluations sur Audible.ca

Évaluations sur Amazon.ca
Il n'y a pas encore de critiques pour ce titre.